ClearPoint Neuro Statistics
Want to see CLPT full AI Analyst Report?
ClearPoint Neuro (CLPT) Stock Statistics & Valuation Metrics
Total Valuation
ClearPoint Neuro has a market cap or net worth of $281.12M. The enterprise value is $405.82M.
- Market Cap
- $281.12M
- Enterprise Value
- $405.82M
Share Statistics
ClearPoint Neuro has 32,054,268 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 32,054,268
- Owned by Insiders
- 3.63%
- Owned by Institutions
- 20.16%
Financial Efficiency
ClearPoint Neuro’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -27.56%.
- Return on Equity (ROE)
- -0.91
- Return on Assets (ROA)
- -0.26
- Return on Invested Capital (ROIC)
- -27.56%
- Return on Capital Employed (ROCE)
- -0.28
- Revenue Per Employee
- 214.95K
- Profits Per Employee
- -148.49K
- Employee Count
- 172
- Asset Turnover
- 0.38
- Inventory Turnover
- 1.71
Valuation Ratios
The current PE Ratio of ClearPoint Neuro is -7.58. ClearPoint Neuro’s PEG ratio is 0.22.
- PE Ratio
- -7.58
- PS Ratio
- 6.46
- PB Ratio
- 10.42
- Price to FCF
- -8.85
- Price to Operating Cash Flow
- -8.83
- PEG Ratio
- 0.22
Income Statement
In the last 12 months, ClearPoint Neuro had revenue of 36.97M and earned -25.54M in profits. Earnings per share was -0.90.
- Revenue
- 36.97M
- Gross Profit
- 22.69M
- Operating Income
- -24.16M
- Pretax Income
- -25.48M
- Net Income
- -25.54M
- EBITDA
- -20.86M
- Earnings Per Share (EPS)
- -0.90
Cash Flow
In the last 12 months, operating cash flow was -32.17M and capital expenditures -1.04M, giving a free cash flow of -33.22M billion.
- Operating Cash Flow
- -32.17M
- Free Cash Flow
- -33.22M
- Free Cash Flow per Share
- -1.07
Dividends & Yields
ClearPoint Neuro pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11.36%
- Earnings Yield
- -12.78%
Stock Price Statistics
- Beta
- 2.02
- 52-Week Price Change
- -47.30%
- 50-Day Moving Average
- 11.82
- 200-Day Moving Average
- 12.83
- Relative Strength Index (RSI)
- 42.18
- Average Volume (3m)
- 662.63K
Important Dates
ClearPoint Neuro upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
ClearPoint Neuro as a current ratio of 5.91, with Debt / Equity ratio of 207.82%
- Current Ratio
- 5.91
- Quick Ratio
- 5.13
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- -0.59
- Interest Coverage Ratio
- -10.12
Taxes
In the past 12 months, ClearPoint Neuro has paid 55.00K in taxes.
- Income Tax
- 55.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
ClearPoint Neuro EV to EBITDA ratio is -11.92, with an EV/FCF ratio of -9.63.
- EV to Sales
- 7.03
- EV to EBITDA
- -11.92
- EV to Free Cash Flow
- -9.63
- EV to Operating Cash Flow
- -9.95
Balance Sheet
ClearPoint Neuro has $46.18M in cash and marketable securities with $73.70M in debt, giving a net cash position of -$27.52M billion.
- Cash & Marketable Securities
- $46.18M
- Total Debt
- $73.70M
- Net Cash
- -$27.52M
- Net Cash Per Share
- -$0.86
- Tangible Book Value Per Share
- $0.24
Margins
Gross margin is 61.39%, with operating margin of -70.56%, and net profit margin of -79.43%.
- Gross Margin
- 61.39%
- Operating Margin
- -70.56%
- Pretax Margin
- -79.50%
- Net Profit Margin
- -79.43%
- EBITDA Margin
- -59.04%
- EBIT Margin
- -69.94%
Analyst Forecast
The average price target for ClearPoint Neuro is $21.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $21.50
- Price Target Upside
- 134.46% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 32.51%
- EPS Growth Forecast
- -46.56%
Scores
- Smart Score
- 3
- AI Score
- 49
